February 5, 2025 · Form 4 insider transaction
ZERBE ROBERT L MD sold 2,500 shares of Vericel Corp at $62.50 per share, a transaction worth $156.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.